Table 2 Univariate and multivariate analyses of the clinicopathological parameters associated with meningioma recurrence.
From: A serum 6-miRNA panel as a novel non-invasive biomarker for meningioma
Variable | Subset | Hazard ratio (95% CI) | p-value |
|---|---|---|---|
Univariate analysis | |||
Gender | Female/Male | 0.660 (0.242–1.805) | 0.419 |
Age | Age ≥ 57/Age < 57 | 1.392 (0.586–3.303) | 0.454 |
WHO | II-III/I | 2.668 (1.076–6.621) | 0.034 |
Resection | Subtotal/Total | 1.770 (0.596–5.262) | 0.304 |
Radiotherapy | Yes/No | 0.720 (0.212–2.444) | 0.598 |
miR-409-3p | High/Low | 2.889 (1.120–7.456) | 0.028 |
miR-224 | Low/High | 2.861 (1.109–7.381) | 0.030 |
Multivariate analysis | |||
Gender | Female/Male | 0.796 (0.275–2.300) | 0.673 |
Age | Age ≥ 57/Age < 57 | 1.367 (0.565–3.307) | 0.487 |
WHO | II-III/I | 2.546 (0.598–10.836) | 0.206 |
Resection | Subtotal/Total | 0.541 (0.117–2.495) | 0.431 |
Radiotherapy | Yes/No | 0.483 (0.130–1.794) | 0.277 |
miR-409-3p | High/Low | 2.809 (1.057–7.465) | 0.038 |
miR-224 | Low/High | 2.558 (0.876–7.476) | 0.086 |
